FDA Adverse Event Malfunction Summary report: N

DUODERM

MDR report key: 17621622 · Received August 25, 2023

Report

Report Number
9618003-2023-02606
Event Type
Malfunction
Date Received
August 25, 2023
Report Date
July 31, 2023
Manufacturer
CONVATEC DOMINICAN REPUBLIC INC
Product Code
NAD
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

E1: (B)(6). BASED ON THE AVAILABLE INFORMATION, THIS EVENT IS DEEMED TO BE A REPORTABLE MALFUNCTION. RETURNED SAMPLE EVALUATION: PHOTOS ASSOCIATED WITH THIS CASE WERE RECEIVED FOR EVALUATION. BATCH RECORD REVIEW: THE LOT 2J00442 WAS MANUFACTURED ON 13 SEP 2022 BODOLAY MANUFACTURING LINE, WITH A TOTAL OF (B)(4). COMPLAINT INVESTIGATOR PERFORMED A BATCH RECORD REVIEW ON 17 AUG, 2023, TO VERIFY IF ALL THE APPLICABLE PROCEDURES WERE FOLLOWED AND NO ISSUES WERE FOUND; ALL THE COMPONENTS FOR ASSEMBLY WERE CORRECT PER BILL OF MATERIALS (BOM) AND ALL THE TOOLING INFORMATION DOCUMENTED WAS ALSO CORRECT. SYSTEM APPLICATION PRODUCT (SAP) MATERIAL 1000854 AND MANUFACTURING ORDER (B)(4). THE BATCH RECORD REVIEW SUPPORTS THAT THERE WERE NO DISCREPANCIES RELATED TO THE ISSUE REPORTED. INVESTIGATION CONCLUSION: AS A RESULT OF THE INVESTIGATION, IN WHICH THE MULTIDISCIPLINARY TEAM PERFORMED A 5WHY EXERCISE TO IDENTIFY THE ROOT CAUSES RELATED WITH THIS DEFECT, IT WAS IDENTIFIED THE FOLLOWING: -AN EVALUATION WAS CARRIED OUT DURING THE SEALING AND PACKAGING PROCESS IN BODOLAY LINE AND IT WAS OBSERVED WHEN THE DRESSING ARE OUT OF THE CENTER OF PACKAGING MATERIAL, GET IN CONTACT WITH SEALING AREA, THE PLATES GET DIRTY, HINDERING THE HEAT TRANSFERENCE OF THE CURRENT PIECES SEALING AND THE FOLLOWING CYCLES CAUSING INCOMPLETE SEALING. -CURRENT VISION SYSTEM SCOPE IT CAN IDENTIFY THE FOLLOWING DEFECTS, LOSS DRESSING, TRAPPED IN THE SEAL, EMPTY BLISTER, DOUBLE DRESSING, CUT DRESSING, RED TAPE. THE OPPORTUNITY IS RELATED TO UPGRADE THE CURRENT VISION SYSTEM TO ENSURE THE CAPTURE OF CHANNEL AND OPEN SEAL DURING MANUFACTURING PRODUCTION. A CORRECTIVE ACTION / PREVENTIVE ACTION (CAPA) PLAN WILL BE GENERATED TO TRACK THE IMPLEMENTATION OF THESE ACTIONS AND MEASURE THE EFFECTIVENESS IN THE PRODUCT AND THE PROCESS. THE INVESTIGATION ASSOCIATED WITH RELATED EVENT RECORD HAS BEEN APPROVED AND WAS COMPLETE. NO ADDITIONAL ACTION IS REQUIRED, AND THIS COMPLAINT WILL BE CLOSED. THIS ISSUE WILL BE MONITORED THROUGH THE POST MARKET PRODUCT MONITORING REVIEW PROCESS. TO DATE NO ADDITIONAL INFORMATION HAS BEEN RECEIVED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED. FDA REGISTRATION NUMBER. REPORTING SITE: 1049092. MANUFACTURING SITE: 9618003.

Description of Event or Problem · 0

IT WAS REPORTED BY A DEALER THAT THE INDIVIDUAL PACKAGING WAS FOUND OPENED. THE PRODUCT WAS NOT USED. THE PHOTOGRAPHS DEPICTING THE ISSUE WERE RECEIVED FROM THE COMPLAINANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
932585 DUODERM DRESSING,WOUND,OCCLUSIVE NAD CONVATEC DOMINICAN REPUBLIC INC 187660 2J00442

Patients

Seq Age Sex Outcome Treatment
1 Unknown